Pharmaceutical Industry in
Hünenberg

Allergopharma AG

Since 1973 · 1–10 empl.

The core activity of Allergopharma AG is the diagnosis and treatment of Type I allergies, particularly through subcutaneous immunotherapy (SCIT) and the development of high-dose, hypoallergenic preparations (allergoids) as well as allergens for diagnostic purposes.

Dermapharm AG

Since 1995 · 21–50 empl.

The core activity of Dermapharm AG is the manufacture, development and distribution of high-quality dermatological and anti-inflammatory drugs, particularly in the field of skin health and allergies.

Ursapharm Schweiz GmbH

Since 1998 · 1–10 empl.

The core activity of URSAPHARM is the development, manufacture and marketing of pharmaceutical products, in particular eye care products such as HYLO and EvoTears, as well as systems and manufacturing solutions for the pharmaceutical industry.

Zaphyr Pharmaceuticals AG

Since 2011 · 11–20 empl.

Zaphyr Pharmaceuticals AG in-licenses, out-licenses and commercializes FDA and European pharmaceutical products and branded generics for chronic diseases in the Middle East and Africa (MEA) region. The company also provides consultancy services (regulatory, market access, marketing & sales, business development and supply-chain support) and pursues manufacturing partnerships to localize production and transfer technology, with a focus on oncology.

DXC I. C. AG

Since 2016 · 1–10 empl.

The core activity of DXC I.C. AG includes: International Trading, Product development and production, Project investments in biotechnology, Marketing development for health, wellness and medical products. The company focuses particularly on the development and production of health products based on the combination of natural ingredients and innovative technologies.